Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

EMvision Medical Devices Ltd

Healthcare AU EMV

1.775AUD
0.07(3.80%)

Last update at 2025-06-06T05:42:00Z

Day Range

1.721.77
LowHigh

52 Week Range

1.632.35
LowHigh

Fundamentals

  • Previous Close 1.71
  • Market Cap150.51M
  • Volume5541
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.74569M
  • Revenue TTM8.06M
  • Revenue Per Share TTM0.10
  • Gross Profit TTM 8.06M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -3.87071M -6.10928M -8.39871M -3.47576M -2.95936M
Minority interest - - - - -
Net income -3.87071M -6.12740M -10.15744M -5.07783M -2.95936M
Selling general administrative 8.17M 7.42M 6.99M 1.91M 2.12M
Selling and marketing expenses - - - - 0.13M
Gross profit - - - - 1.41M
Reconciled depreciation 0.34M 0.24M 0.11M - -
Ebit -3.83543M -6.09116M -8.38888M -3.47516M -2.95860M
Ebitda -3.49342M -5.84782M -8.27492M -3.47516M -2.95860M
Depreciation and amortization 0.34M 0.24M 0.11M - -
Non operating income net other - - - - -
Operating income -3.83543M -6.09116M -8.38888M -3.47516M -2.95860M
Other operating expenses 10.93M 10.47M 10.18M 5.11M 4.37M
Interest expense 0.04M 0.02M 0.00984M 0.00060M 0.00076M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.04M 0.02M 0.05M 0.00060M 0.00076M
Net interest income 0.08M -0.00248M 0.04M 0.04M -0.00076M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 7.01M 0.02M 1.76M 1.60M -
Total revenue 4.59M 2.39M 0.52M 0.98M 1.14M
Total operating expenses 10.93M 10.47M 10.18M 5.11M 4.37M
Cost of revenue - - - - -
Total other income expense net 6.97M -0.01812M -0.00984M -0.00060M -0.00076M
Discontinued operations - - - - -
Net income from continuing ops -3.87071M -6.10928M -8.39871M -3.47576M -2.95936M
Net income applicable to common shares -3.87071M -6.10928M -8.39871M -3.47576M -2.95936M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 23.97M 11.52M 8.51M 10.77M 6.01M
Intangible assets - 0.48M 0.48M 0.48M 0.48M
Earning assets - - - - -
Other current assets 0.35M 0.27M 0.07M 0.12M 0.08M
Total liab 5.46M 6.40M 1.43M 0.72M 0.49M
Total stockholder equity 18.52M 5.12M 7.08M 10.05M 5.52M
Deferred long term liab - - - - -
Other current liab 1.01M 2.30M 0.68M 0.48M 0.17M
Common stock 41.57M 26.23M 23.21M 21.40M 11.96M
Capital stock - 26.23M 23.21M 21.40M 11.96M
Retained earnings -26.51575M -25.65886M -21.78815M -15.67887M -7.28016M
Other liab - 0.05M 0.03M - -
Good will - - - - -
Other assets - - - - -
Cash 18.60M 9.97M 6.80M 9.69M 5.41M
Cash and equivalents - - - - -
Total current liabilities 3.41M 6.04M 0.85M 0.68M 0.49M
Current deferred revenue 1.05M 0.68M -0.19688M -0.16933M -0.16933M
Net debt -15.70122M -6.92803M -6.06122M -9.47639M -5.40904M
Short term debt 1.07M 2.73M 0.20M 0.17M 0.17M
Short long term debt - 2.50M - - -
Short long term debt total 2.90M 3.04M 0.74M 0.21M 0.21M
Other stockholder equity - 4.55M 5.66M 4.33M 0.84M
Property plant equipment - 0.80M 0.96M 0.32M -
Total current assets 21.87M 10.23M 7.07M 9.98M 5.53M
Long term investments - - - - -
Net tangible assets - 4.64M 6.60M 9.57M 5.04M
Short term investments - 0.31M 0.18M - -
Net receivables 2.92M - 0.07M 0.12M 0.08M
Long term debt - - - - -
Inventory - - - - -0.03803M
Accounts payable 0.29M 0.33M 0.18M 0.19M 0.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 3.46M 4.55M 5.66M 4.33M 0.84M
Additional paid in capital - - - - -
Common stock total equity - - - - 11.96M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.65M -1.28336M -1.43807M -0.79865M -0.48000M
Deferred long term asset charges - - - - -
Non current assets total 2.10M 1.28M 1.44M 0.80M 0.48M
Capital lease obligations - 0.54M 0.74M 0.21M -
Long term debt total - 0.31M 0.54M 0.04M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.18729M -0.19112M -0.12725M - -
Change to liabilities 2.36M 0.04M -0.05321M -0.02116M 0.08M
Total cashflows from investing activities -0.18729M -0.19112M -0.12725M -0.12725M -0.12725M
Net borrowings 2.53M -0.17510M -0.09767M -0.09767M -0.09767M
Total cash from financing activities 2.52M 1.08M 8.90M 4.28M 5.58M
Change to operating activities -0.00067M 0.11M -0.09091M 0.08M -0.05681M
Net income -3.87071M -6.10928M -8.39871M -3.47576M -2.95936M
Change in cash 3.17M -2.89048M 5.41M 1.03M 3.37M
Begin period cash flow 6.80M 9.69M 4.28M 4.38M 1.02M
End period cash flow 9.97M 6.80M 9.69M 5.41M 4.38M
Total cash from operating activities 0.83M -3.78204M -4.49452M -3.25538M -2.21526M
Issuance of capital stock -0.00574M 1.26M 9.00M 4.28M 5.58M
Depreciation 0.34M 0.24M 0.11M 0.11M 0.11M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.07M 0.05M 0.05M 0.05M 0.05M
Sale purchase of stock -0.00574M 1.26M 9.00M 4.28M 5.58M
Other cashflows from financing activities 2.75M -0.19112M -0.12725M -3.25538M -2.21526M
Change to netincome 1.93M 1.89M 3.93M 0.12M 0.72M
Capital expenditures 0.19M 0.19M 0.13M 0.13M 0.13M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.07M 0.05M 1.33M 0.05M 0.00000M
Stock based compensation 1.91M 1.88M 3.93M 0.12M -
Other non cash items 4.36M 2.09M -0.13864M 0.05M 2.96M
Free cash flow 0.65M -3.97316M -4.62177M -3.25538M -2.21526M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
EMV
EMvision Medical Devices Ltd		 0.07 3.80% 1.77 - - 18.67 9.49 -21.5294
COH
Cochlear Ltd		 -2.78 1.02% 268.49 48.10 38.76 7.68 9.45 7.58 29.32
PNV
Polynovo Ltd		 -0.03 2.24% 1.31 134.00 63.69 8.01 12.26 7.90 99.22
IMR
Imricor Medical Systems Inc		 -0.04 2.35% 1.66 - - 552.77 3.97 372.97 -2.6027
EBR
Ebr Systems Inc CDR		 0.06 4.96% 1.17 - - - 18.15 -3.6785

Reports Covered

Stock Research & News

View All

Profile

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.

EMvision Medical Devices Ltd

65 Epping Road, Macquarie Park, NSW, Australia, 2113

Key Executives

Name Title Year Born
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. CEO, MD & Director NA
Mr. Scott Kirkland Exec. Director NA
Ms. Emma Waldon CFO & Company Sec. 1976
Dr. Konstanty Bialkowski Head of Technology Devel. NA
Prof. Stuart Crozier B.E., M.Sc., Ph.D. Chairman of Clinical Advisory Board & Chief Scientific Officer NA
Mr. Robert Tiller Head of Design NA
Ms. Forough Khandan Head of New Product Devel. NA
Dr. Merricc Edgar-Hughes Ph.D. Head of Quality & Regulatory Affairs NA
Dr. Konstanty Bialkowski Head of Tech Development NA
Mr. Scott Kirkland CEO, MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.